JP Morgan analyst Anthony Paolone downgrades American Homes 4 Rent (NYSE:AMH) from Overweight to Neutral and announces $36 price target.
INmune Bio Reports First Patient Dosed In Phase 2 XPro1595 Trial For Treatment Of Neuroinflammation As Cause Of Alzheimer’s
INmune Bio, Inc. (NASDAQ:INMB) (“INMB” or “the Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune